By CPC Scientific Inc.
[..] to Manufacture Neoantigen Peptides for the PANDA (Personalized and Adaptive) Cancer Vaccine Program.
immunoSCAPE Pte Ltd ("immunoSCAPE" or the "Company"), a leader in immune profiling, today announced the establishment of its first US office in Cambridge, MA.
SMi Reports: This year's Immuno-Oncology conference, taking place 26th - 27th September in London, aims to address the issues and challenges burdening the industry, as well as the promising advancements made recently.
By The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) will join forces with Axis Therapeutics, a newly established joint venture by two global biopharmaceutical companies – Athenex, Inc.
By Creative Peptides
As one of the leading peptide manufacturers, Creative Peptides announced to introduce neoantigen peptides vaccine for researchers in both academic and industrial community on May 29, 2018.
By Maxygen LLC
The new Maxygen brings together scientists experienced in the application of molecular breeding paired with an accomplished leader in contract manufacturing to offer custom directed evolution programs across all sectors of biotech.
Results of a recent sarcoma immunotherapy clinical trial initiated by SARC (Sarcoma Alliance for Research Through Collaboration) have been published in The Lancet Oncology, the world-leading clinical oncology periodical publishing high-quality,...